We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Franklin FTSE Japan ETF
FLJP
$3.86B
| $311K | 0.01% |
+9,663
| New | +$295K |
|
1352
Latham Group
SWIM
$660M
| $308K | 0.01% |
48,345
+23,452
| +94% | +$136K |
|
1353
Taylor Devices
TAYD
$176M
| $304K | 0.01% |
+7,012
| New | +$249K |
|
1354
Klaviyo
KVYO
$5.8B
| $301K | 0.01% |
8,955
-26,177
| -75% | -$829K |
|
|
BRDG
1355
DELISTED
Bridge Investment Group
BRDG
| $299K | 0.01% |
+29,848
| New | +$278K |
|
1356
Independent Bank Corp
IBCP
$796M
| $298K | 0.01% |
+9,208
| New | +$285K |
|
|
ONL
1357
Orion Office REIT
ONL
$151M
| $296K | 0.01% |
+138,739
| New | +$264K |
|
1358
Townsquare Media
TSQ
$105M
| $295K | 0.01% |
+37,355
| New | +$264K |
|
1359
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.36B
| $295K | 0.01% |
+4,704
| New | +$283K |
|
1360
InfuSystem Holdings
INFU
$197M
| $294K | 0.01% |
+47,111
| New | +$260K |
|
|
SPNS
1361
DELISTED
Sapiens International
SPNS
| $293K | 0.01% |
+10,019
| New | +$279K |
|
1362
Tecnoglass
TGLS
$1.99B
| $293K | 0.01% |
+3,788
| New | +$294K |
|
1363
International Money Express
IMXI
$389M
| $293K | 0.01% |
29,025
-4,793
| -14% | -$54.7K |
|
1364
CryoPort
CYRX
$753M
| $292K | 0.01% |
+39,114
| New | +$243K |
|
1365
National Healthcare
NHC
$3.57B
| $292K | 0.01% |
+2,726
| New | +$272K |
|
1366
News Corp Class B
NWS
$17.7B
| $292K | 0.01% |
+8,502
| New | +$269K |
|
|
KG
1367
Kestrel Group
KG
$66.1M
| $291K | 0.01% |
+10,986
| New | +$254K |
|
1368
Acumen Pharmaceuticals
ABOS
$152M
| $291K | 0.01% |
+250,848
| New | +$270K |
|
1369
Algoma Steel
ASTL
$450M
| $291K | 0.01% |
42,190
-52,656
| -56% | -$294K |
|
|
VERV
1370
DELISTED
Verve Therapeutics
VERV
| $289K | 0.01% |
25,736
-25,705
| -50% | -$147K |
|
1371
Mineralys Therapeutics
MLYS
$2.32B
| $288K | 0.01% |
+21,280
| New | +$308K |
|
1372
Geospace Technologies
GEOS
$84M
| $288K | 0.01% |
+20,184
| New | +$151K |
|
1373
Pacira BioSciences
PCRX
$1.04B
| $287K | 0.01% |
+11,996
| New | +$302K |
|
|
PENG
1374
Penguin Solutions Inc
PENG
$2.24B
| $286K | 0.01% |
+14,422
| New | +$261K |
|
1375
Lifestance Health
LFST
$4.15B
| $283K | 0.01% |
54,807
-31,839
| -37% | -$191K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.